首页> 外文学位 >Survival analyses of adult AIDS cases in Riverside and San Bernardino counties, California, between 1993 and 1999
【24h】

Survival analyses of adult AIDS cases in Riverside and San Bernardino counties, California, between 1993 and 1999

机译:1993年至1999年间加利福尼亚州里弗赛德和圣贝纳迪诺县的成人艾滋病病例的生存分析

获取原文
获取原文并翻译 | 示例

摘要

In recent years, a longer survival after AIDS diagnosis and a sharp decline in AIDS incidence and deaths have been observed in the United States. This study is a follow-up study of 3,578 reported AIDS cases to the AIDS surveillance system in Riverside and San Bernardino Counties, California between January 1993 and December 1999. We compared our results using 5 analysis methods: Kaplan-Meier survival, time trend analysis, Cox regression, Spline survival regression, and multivariate multiple decrement life-table analysis program (MMDLAP).;Our study's results using Cox regression show that cases with a history of antiretroviral therapy (ART), younger age, and higher CD4+ T lymphocyte at AIDS diagnosis are significant predictors of AIDS survival. Survival improves with calendar time in all groups. Cases with a history of ART showed a hazard ratio (HR) of 0.62 for cases with CD4+ T lymphocyte count of 50 cells/mul (95% CI: 0.48, 0.79), HR of 0.57 for cases with 100 cells/mul (95% Cl: 0.45, 0.72), and HR of 0.49 for cases with 200 cells/mul (95% CI: 0.31, 0.77) at the age of 40 years after controlling for significant confounders. Survival appears to improve with secular time. For every 10 years increase in age at diagnosis, HR increased by 26 percent (HR 1.26, 95% CI: 1.02, 1.56) and for every 50 cells/mul increase in CD4+ T lymphocyte count, HR decreased by 31 percent (HR 0.69, 95% CI: 0.59, 0.82) in the group that did receive ART treatment. Compared to AIDS cases diagnosed in 1993, cases diagnosed in 1994-95 had an HR of 0.77 (95% CI: 0.62, 0.94); cases diagnosed in 1996--97 had an HR of 0.40 (95% CI: 0.31, 0.52); cases diagnosed in 1998--99 had an HR of 0.48 (95% CI: 0.35, 0.66).;Traditional Cox regression gives estimates of survival as a monotonic exponential function in a continuous Cox regression, and a step function in categorical Cox regression while Spline regression offers a smooth representation of a complex pattern of changes of hazard ratio (HR). Moreover, categorical Cox regression overestimates HR in the beginning and underestimates it in the end compared to Spline regression. MMDLAP is intuitive in estimating risk of death and mean survival time in defined time periods and also estimates risk ratio (RR) as HR with values similar to Cox regression.;Use of potent ART in a community setting is as effective as it has been in clinical trials. The effectiveness of antiretroviral therapy on survival can be observed from surveillance data collected at the community level.
机译:近年来,在美国发现了艾滋病诊断后的更长生存期以及艾滋病发病率和死亡人数的急剧下降。这项研究是对1993年1月至1999年12月在加利福尼亚河滨和圣贝纳迪诺县艾滋病监测系统中报告的3,578例AIDS病例的后续研究。我们使用5种分析方法对我们的结果进行了比较:Kaplan-Meier生存率,时间趋势分析,Cox回归,样条生存回归和多元多元递减寿命表分析程序(MMDLAP)。我们使用Cox回归的研究结果显示,抗病毒治疗史(ART),年龄较小且CD4 + T淋巴细胞较高的患者艾滋病诊断是艾滋病生存的重要预测指标。所有组的生存时间都随着日历时间的增加而提高。有ART病史的患者对CD4 + T淋巴细胞计数为50个细胞/ mul的患者的危险比(HR)为0.62(95%CI:0.48,0.79),对于100个细胞/ mul的病例的HR为0.57在控制显着混杂因素后40岁时,如果细胞数为200细胞/ mul(95%CI:0.31、0.77),则Cl:0.45、0.72)和HR为0.49。存活时间似乎随着世俗的时间而提高。诊断时年龄每增加10年,HR就会增加26%(HR 1.26,95%CI:1.02,1.56),CD4 + T淋巴细胞计数每增加50个细胞/ mul,HR就会减少31%(HR 0.69,在接受ART治疗的组中,有95%CI:0.59、0.82)。与1993年诊断出的艾滋病病例相比,1994-95年诊断出的病例的HR为0.77(95%CI:0.62,0.94)。 1996--97年诊断的病例的HR为0.40(95%CI:0.31,0.52); 1998--99年诊断的病例的HR为0.48(95%CI:0.35,0.66);传统的Cox回归以连续Cox回归的单调指数函数估算生存率,而分类Cox回归以阶跃函数估算生存率。样条回归可以平滑表示危险比(HR)变化的复杂模式。此外,与样条回归相比,分类Cox回归在一开始就高估了HR,而在最后却低估了HR。 MMDLAP可以直观地估算出特定时间段内的死亡风险和平均生存时间,还可以将风险比(RR)估算为HR,其值与Cox回归相似。在社区环境中使用有效抗逆转录病毒疗法的效果与过去一样有效。临床试验。从社区一级收集的监测数据可以观察到抗逆转录病毒疗法对生存的有效性。

著录项

  • 作者

    Myint, Tun.;

  • 作者单位

    Loma Linda University.;

  • 授予单位 Loma Linda University.;
  • 学科 Public health.
  • 学位 Dr.P.H.
  • 年度 2002
  • 页码 147 p.
  • 总页数 147
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号